Tumor glycolytic profiling through F-FDG PET/CT predicts immune checkpoint inhibitor efficacy in advanced NSCLC by Saulo Brito Silva, Carlos Wagner S. Wanderley, José Flavio Gomes Marin, Mariana Petaccia de Macedo, Ellen Caroline Toledo do Nascimento, Fernanda Frozoni Antonacio, Caroline Sales Figueiredo, Mateus Trinconi Cunha, Fernando Q. Cunha, Gilberto de Castro Junior

Get full text